Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivo
Open Access
- 9 October 2007
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 97 (9), 1234-1241
- https://doi.org/10.1038/sj.bjc.6604021
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in miceAnti-Cancer Drugs, 2007
- Heteroaryl substituted titanocenes as potential anti-cancer drugsJournal of Inorganic Biochemistry, 2006
- Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cellsApoptosis, 2006
- Apoptosis: mechanisms and relevance in cancerAnnals of Hematology, 2005
- Heteroaryl substitutedansa-titanocene anti-cancer drugs derived from fulvenes and titanium dichlorideApplied Organometallic Chemistry, 2005
- Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichlorideJournal of Inorganic Biochemistry, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent PathwaysThe Journal of pharmacology and experimental therapeutics, 2002
- Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast CancerOncology Research and Treatment, 2000
- Premature p34 cdc2 Activation Required for ApoptosisScience, 1994